CLINICAL_TRIALS trial_result · 2019-05-06

Clinical Trial Update: Efficacy and Safety of LEO 19123 Cream in the Treatment of Psoriasis Vulgaris [Phase 2]

A phase 2 trial evaluating the efficacy and safety of LEO 19123 cream for psoriasis vulgaris has completed, with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: LEO Pharma | Conditions: Psoriasis Vulgaris | Phase 2 | Status: COMPLETED | Results posted: 2019-05-06